Immunoglobulin A vasculitis nephritis: Current understanding of pathogenesis and treatment

doi:10.5527/wjn.v12.i4.82

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3484)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

102

WORD

HTML

1915

Figures (1-2)

222

Tables (1-2)

276

Sum=2546

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

192

Download

267

Sum=459

Publishing Process of This Article

Item

Count

Browse

114

Download

205

Sum=319

Sep 25, 2023 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Nephrol. Sep 25, 2023; 12(4): 82-92
Published online Sep 25, 2023. doi: 10.5527/wjn.v12.i4.82

Open in New Tab Full Size Figure Download Figure

Figure 1 Pathogenesis and drug treatment for immunoglobulin A vasculitis and nephritis. Gd-IgA1: Galactose-deficient-immunoglobulin A; AECA: Anti-endothelial cell antibodies; RAAS: Renin-angiotensin-aldosterone system; ACEI: Angiotensin-converting enzyme inhibitors; ARBs: Angiotensin receptor blockers; AZA: Azathioprine; MMF: Mycophenolate mofetil; CsA: Cyclosporine A; CYC: Cyclophosphamide; CNIs: Calcineurin inhibitors.

Open in New Tab Full Size Figure Download Figure

Figure 2 Therapeutic algoritm for immunoglobulin A vasculitis and nephritis. ACEI: Angiotensin-converting enzyme inhibitors; ARBs: Angiotensin receptor blockers; IgAVN: Immunoglobulin A vasculitis nephritis; AZA: Azathioprine; MMF: Mycophenolate mofetil; CYC: Cyclophosphamide; CNIs: Calcineurin inhibitors; CsA: Cyclosporine A.

Citation: Amatruda M, Carucci NS, Chimenz R, Conti G. Immunoglobulin A vasculitis nephritis: Current understanding of pathogenesis and treatment. World J Nephrol 2023; 12(4): 82-92
URL: https://www.wjgnet.com/2220-6124/full/v12/i4/82.htm
DOI: https://dx.doi.org/10.5527/wjn.v12.i4.82